Europe’s Revised Biosimilars Guideline Allows Non-EU Data In Applications
This article was originally published in The Pink Sheet Daily
Executive Summary
Some data from a non-European version of a reference product can be used in biosimilar marketing applications, a revised overarching biosimilars guideline from European regulators says. It also notes interchangeability is a matter for individual European countries to decide.